Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Srikar N. Adibhatla"'
Autor:
Navid Adnani, Emmanuel Vazquez-Rivera, Srikar N. Adibhatla, Gregory A. Ellis, Doug R. Braun, Tim S. Bugni
Publikováno v:
Marine Drugs, Vol 13, Iss 10, Pp 6082-6098 (2015)
With respect to bacterial natural products, a significant outcome of the genomic era was that the biosynthetic potential in many microorganisms surpassed the number of compounds isolated under standard laboratory growth conditions, particularly among
Externí odkaz:
https://doaj.org/article/9dee2ea4bc7e45d78a182bd5388a9750
Autor:
Scott W. Simpkins, Fan Zhang, Marc G. Chevrette, Lingjun Li, Scott R. Rajski, Cameron R. Currie, Christopher J. Thompson, Srikar N. Adibhatla, Doug R. Braun, Bradon R. McDonald, Justin Nelson, Tim S. Bugni, Navid Adnani, Qing Yu, Chad L. Myers, Jeff S. Piotrowski
Publikováno v:
ACS Chemical Biology. 12:3093-3102
Advances in genomics and metabolomics have made clear in recent years that microbial biosynthetic capacities on Earth far exceed previous expectations. This is attributable, in part, to the realization that most microbial natural product (NP) produce
Autor:
Srikar N. Adibhatla, E Vazquez-Rivera, Gregory A. Ellis, Navid Adnani, Doug R. Braun, Tim S. Bugni
Publikováno v:
Marine Drugs
Marine Drugs, Vol 13, Iss 10, Pp 6082-6098 (2015)
Volume 13
Issue 10
Pages 6082-6098
Marine Drugs, Vol 13, Iss 10, Pp 6082-6098 (2015)
Volume 13
Issue 10
Pages 6082-6098
With respect to bacterial natural products, a significant outcome of the genomic era was that the biosynthetic potential in many microorganisms surpassed the number of compounds isolated under standard laboratory growth conditions, particularly among
Autor:
Srikar N. Adibhatla, Gregory A. Ellis, E Vazquez-Rivera, Navid Adnani, Doug R. Braun, Tim S. Bugni
Publikováno v:
Planta Medica. 81